TWST Twist Bioscience, Inc. Quick Ratio

Public company logo of twistbioscience.com (TWST)

Twist Bioscience (TWST) is recognized as the gold standard in synthetic DNA creation, maintaining absolute authority within the scientific community through its high-precision silicon systems. The deep integration of its solutions into the research cycles of pharma behemoths creates long-term customer stickiness and stable demand. Simultaneously, the company is aggressively expanding its influence by undercutting competitors via its unique synthesis method. This price chart on GURU.Markets shows a value of 2.40.

Twist Bioscience Corp (TWST) Interim Coverage Ratio: for the period 07/04/2022 - 10/29/2026
Finished products of twistbioscience.com

For synthetic biology pioneer Twist Bioscience (TWST), which is scaling its "Factory of the Future," maintaining high liquidity levels is critical for the seamless funding of expansion and the development of the Express Genes service. By analyzing the changes in the quick ratio on GURU.Markets, an investor can see the company's ability to meet short-term obligations using only cash and accounts receivable, excluding less liquid inventories.

Competitors of Twist Bioscience (TWST)

TEM (Tempus) - Quick Liquidity Indicator|Quick Liquidity Indicator Qiagen Corp|IONS (Ionis Pharmaceuticals) - Quick Ratio|repligen.com (RGEN) - Interim Coverage Ratio|Quick Liquidity Avidity Biosciences, Inc. (RNA)|Interim Coverage Ratio CRISPR Therapeutics Inc|Sema4 - Quick Liquidity Indicator|Intermediate Liquidity Ratio RARE (Ultragenyx Corp)|BEAM: Quick Liquidity Indicator|Intermediate Coverage Ratio SRPT (sarepta.com)|TXG: Quick Ratio|NTLA (Intellia Therapeutics Inc) - Quick Liquidity|STOK (Stoke) - Quick Ratio|BioLife (BLFS) - Interim Coverage Ratio|Quick Liquidity Wave Life Sciences (WVE)|MAZE - Immediate Liquidity|Quick Liquidity Sionna Therapeutics SION|Interim Coverage Ratio Prime Medicine Inc (PRME)|Taysha - Quick Ratio|uniQure Pharma (QURE) - Quick Liquidity Indicator|MGTX: Quick Ratio|RGNX - Interim Coverage Ratio|SLDB (Solid Biosciences) - Quick Ratio|Immediate Liquidity Ocugen Inc OCGN|Quick Liquidity Pacific Biosciences of California (PACB)|Benitec Corp - Immediate Liquidity Ratio|Quick Ratio DSGN (Design Therapeutics)|RCKT - Quick Liquidity Indicator|4D Molecular Therapeutics, Inc. - Quick Ratio|Immediate Liquidity Lexeo Therapeutics|KRRO (korrobio.com) - Quick Liquidity Indicator|EDIT: Intermediate Liquidity Ratio|Quick Liquidity Indicator SLN|Quick Liquidity Indicator ProQR Therapeutics NV (PRQR)|Quick Liquidity Codexis, Inc. (CDXS)|Interim Coverage Ratio Sangamo Therapeutics Inc.|Nautilus Bio - Quick Liquidity Indicator|Intermediate Liquidity Ratio MGX (Metagenomi Therapeutics)|Precision BioSciences, Inc. - Quick Ratio|GBIO (Generation Bio Co.) - Immediate Liquidity Ratio|Boundless Bio (BOLD) - Quick Liquidity|Immediate Liquidity Ratio XCUR|IMNN (Imunon Inc) - Quick Ratio|Quick Ratio RXi Pharmaceuticals|Quick Liquidity Indicator MBIO (Mustang Bio, Inc.)|Intermediate Liquidity Ratio RNAZ|Bionano Genomics - Quick Liquidity Indicator|APDN - Quick Liquidity Indicator|Bluebird Bio - Quick Ratio|Interim Coverage Ratio ImmunoPrecise Antibodies IPA|Omega Therapeutics (OMGA) - Quick Liquidity|OMIC - Interim Coverage Ratio|Quick Liquidity Indicator RGLS|SYRS (Syros Pharmaceuticals Inc.) - Intermediate Liquidity Ratio|Quick Liquidity Indicator TBIO (Codex DNA)|TCON (TRACON Pharmaceuticals, Inc) - Intermediate Coverage Ratio|Quick Ratio UBX (Unity Biotechnology)